Non-Hodgkin
Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
... and HHV-6B. Most of children are infected by one of two subgroup A or B before the age of two year. No clear disease have been defined for HHV-6A. HHV- 6B is causative agent for exanthema subitum (rose- ola) meningitis, ...
6
Prevalence of Hepatitis C virus Genotype 3a in patients with Hodgkin and Non-Hodgkin Lymphoma
... or Hodgkin lymphoma (HL) is characterized by multinuclear Reed-Sternberg cells (RS cells) ...(12). Non-Hodgkin’s lymphoma (NHL) is a lymph- oproliferative disorder which comprises different hematologic ...
6
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non Hodgkin and Hodgkin lymphomas
... of non-Hodgkin and Hodgkin lymphoma cell lines, including 2/6 diffuse large B-cell (DLBCL), 1/2 peripheral T cell lymphomas, 5/5 Burkitt, 6/7 Hodgkin and 2/3 nasal killer (NK)/T-cell lymphoma ...
7
Apoptosis inhibition or inflammation: the role of NAIP protein expression in Hodgkin and non-Hodgkin lymphomas compared to non-neoplastic lymph node
... 39 Hodgkin Lymphoma and 23 Non Hodgkin Lymphoma cases in comparison with 39 control samples (30 normal and 9 Reactive Lymphoid Hyperplasia (RLH) lymph nodes) using semi-quantitative immuno-flourecent ...
9
Understanding Low Grade Non Hodgkin Lymphoma
... How common is it? It is the most common type of low-grade lymphoma. In Ireland, it makes up about half of all low grades and about one-fifth of all non-Hodgkin lymphomas. It is more common in people over 50 ...
45
Expanded use of rituximab in the management of non-Hodgkin lymphoma
... untreated non-Hodgkin lymphoma (NHL) conventional chemotherapy supplemented by rituximab (R-chemotherapy) was shown to be more effective than chemotherapy ...as Hodgkin lymphoma (HL) and ...
9
Fundamentals of the Management of Non Hodgkin Lymphoma
... The incidence of Non-Hodgkin’s lymphomas (NHL) is rising worldwide and if not adequately treated carries a high mortality rate. The pattern and frequency of NHL vary in different populations and geographical ...
8
MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
... Abstract: B-cell non-Hodgkin lymphomas (NHLs) are lymphoproliferative disorders that can arise at different stages of B-cell development. Even though molecular classification of NHL has allowed for more ...
16
The role of bendamustine in the treatment of indolent non-Hodgkin lymphoma
... Abstract: There is no consensus on recommendations for the treatment of relapsed and refractory indolent non-Hodgkin lymphoma (NHL). Bendamustine hydrochloride (bendamustine) has recently been approved for ...
11
Non-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions
... of non-Hodgkin ...both non-Hodgkin lymphoma and gastrointestinal stromal tumors, there is no common molecular pathway between these two ...
6
Pediatric Non Hodgkin Lymphoma: A Retrospective 7 Year Experience in Children & Adolescents with Non Hodgkin Lymphoma Treated in King Fahad Medical City (KFMC)
... ically for the t (8; 14) (q24; q32) a characteristic genetic feature of Burkitt’s Lymphoma was ob- tained from 21 patients, variant rearrangement was observed in 3/21 samples and complex chromosomes karyotype in addition ...
16
Clinicopathological Properties of Non-Hodgkin Lymphomas in the South-West of Turkey
... Objective: Non-Hodgkin Lymphomas, which have numerous histological subgroups, entail various biological behaviour, clinical properties and epidemiological ...of Non-Hodgkin Lymphoma patients ...
5
Evaluation of Epstein - Barr virus Frequency in Paraffin-Embedded Tissues of Hodgkin and Non-Hodgkin Lymphoma Patients in Kerman Province
... cases were positive for EBV. These EBV positive cases in Hodgkin's lymphoma included 3 (37,50%) female and 5 (62,50%) male. These EBV positive cases in Non- Hodgkin's lymphoma included 1(37,50%) female and 2 ...
7
A Physiological Study of Albumin Level for Patients with Non-Hodgkin Lymphomas
... Cancer is a major public health problem in different countries around the world. Recent studies reported by the World Health Organization (WHO) expected that cancer will affect approximately 15 million people at the ...
6
Allogeneic and autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide conditioning therapy for relapsed/refractory non Hodgkin lymphoma
... The optimal stem cell transplantation (SCT) con- ditioning therapy for relapsed/refractory non- Hodgkin lymphoma (NHL) is not clearly defined. In a retrospective analysis, we examined 25 pa- tients with ...
9
Factors influencing Non-Hodgkin Lymphoma survivors' quality of life
... Non-Hodgkin lymphoma (NHL) is the sixth most common cancer in the United States (US), with more than 65,540 new NHL diagnoses and 20,210 deaths expected in 2010 (American Cancer Society, 2010). Incidence ...
112
Gastrointestinal non-Hodgkin lymphomas
... in non-Hodgkin lymphoma (NHL), primary gastrointestinal NHL (gNHL) is a rare problem which concerns about 10–15% of NHL patients and 30–40% of extranodal NHL ...
6
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
... eight non-malignant centroblast ...and non-malignant ...indels. Non-synonymous SNVs were by far the most common type of change observed, with ...
6
Understanding High Grade Non Hodgkin Lymphoma
... For more information on stem cell transplants, call the National Cancer Helpline on 1800 200 700 or visit a Daffodil Centre.. Ask for a copy of the booklets, Understanding Stem Cell Coll[r] ...
43
Bendamustine in the treatment of non-Hodgkin’s lymphomas
... The types of patients in trials of bendamustine for treat- ment of NHL have varied, probably accounting for some of the differences in results among studies. Overall response rates (OR) have varied from 73% to 100%; ...
11